Illicit cocaine and methamphetamine containing opioids
Following ongoing identification of cases of opioid overdose after use of substances expected to be cocaine or methamphetamine in NSW, a Safety Notice for Clinicians (012/26) has been published on the NSW Health website. The Safety Notice will also be distributed via the Clinical Excellence Commission’s Safety Alert Broadcast System.
Additionally, one person has died and multiple people in four separate incidents across Victoria have required emergency care because they experienced heroin overdose after using what they thought was cocaine or methamphetamine. Specialised blood tests showed evidence of heroin as well as cocaine and methamphetamine, suggesting that heroin may have been mixed into these drugs (‘adulteration’).
Please see the drug alert issued by the Victorian Department of Health.
Please share this information with your patients, peers, clients, and professional networks as appropriate.
Know the signs of opioid overdose and access naloxone
Signs of opioid overdose include breathing slowly and reduced consciousness (meaning someone is hard to wake up). In some cases, the person may also have tiny pupils. More information about opioid overdose symptoms can be found on the Penington Institute website.
Naloxone is a life-saving medicine that can temporarily reverse an opioid overdose. Naloxone is available in an easy to use nasal spray, and as a pre-filled injection.
Community Notice from CanTEST: Medetomidine found in green ‘S 90 3’ pill 4 November 2026 CanTEST Health & Drug Checking Service has published a Community Notice on social media. It is also viewable as a webpage on The Know. ‘A green rectangular pill marked ‘S 90 3’ and two break lines splitting…
Supporting Patient Choice for Planned Surgery and Shorter Wait Times In accordance with section 68 of the Health Services Act 1997, patients may access elective surgery at a hospital other than their local hospital. Discussing available options for surgery may help suitable patients access surgery sooner where they are willing…
New Opioid Treatment Program legislative requirements and supporting resources On 5 November 2026, the Medicines, Poisons and Therapeutic Goods Regulation 2026 commenced, introducing changes to the management of patients receiving treatment under the NSW Opioid Treatment Program (OTP). The new legislative framework strengthens safeguards for patients and the community, supports…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update. In this week’s update, read about: Giving MenB with Other Vaccines? Australian Evidence Supports the Approach Empowering immunisation conversations A spotlight on whooping cough Feedback Education Giving MenB with Other Vaccines? Australian Evidence Supports the Approach A recent Australian study published…
CESPHN releases Annual Report 2025-26 Central and Eastern Sydney PHN has released its Annual Report for 2025-26, providing a comprehensive overview of the milestones, challenges and achievements that shaped our work over the past year. The report highlights the impact of our programs and partnerships across the region, showcases key…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update. In this week’s update, read about: Vaccine reconstitution errors Whooping Cough Day Preparing patients for overseas travel: Vaccination advice and resources Education Vaccine reconstitution errors The Therapeutic Goods Administration (TGA) is reminding health professionals to carefully follow product-specific vaccine preparation instructions,…